Source: Eur Respir J, 55 (2) 1901697; 10.1183/13993003.01697-2019
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Frits I. Mulder, Marcello Di Nisio, Cihan Ay, Marc Carrier, Floris T.M. Bosch, Annelise Segers, Noémie Kraaijpoel, Michael A. Grosso, George Zhang, Peter Verhamme, Tzu-Fei Wang, Jeffrey I. Weitz, Saskia Middeldorp, Gary Raskob, Ludo F.M. Beenen, Harry R. Büller, Nick van Es. Clinical implications of incidental venous thromboembolism in cancer patients. Eur Respir J, 55 (2) 1901697; 10.1183/13993003.01697-2019

Member's Comments

No comment yet.

Related content which might interest you: Venous thromboembolism in lung cancer with clinical analysis of 89 cases Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Risk of venous thromboembolism in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004 Clinical usefulness of D-dimer in cancer patients with suspected pulmonary embolism Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003 Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016 Year: 2017 Treatment and prevention of cancer-associated venous thromboembolism Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management Year: 2021 Incidental venous thromboembolism, detected by chance, but still venous thromboembolism Source: Eur Respir J, 55 (2) 2000028; 10.1183/13993003.00028-2020 Year: 2020 Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review Source: Eur Respir J 2015; 45: 201-210 Year: 2015 Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018 Year: 2018 Risk factors in patients with venous thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 239s Year: 2002 Silent venous thromboembolism (VTE) in patients undergoing thoracic surgery in the course of lung cancer. Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 Does platelet index examination provide clinical benefit in coexistence of pulmonary thromboembolism and cancer? Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 Clinical presentation and outcome of venous thromboembolism in COPD Source: Eur Respir J 2012; 39: 862-868 Year: 2012 Venous thromboembolism and pulmonary cancer: A ten years series Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Clinical profile and mortality of patients with pulmonary embolism and cancer Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015 The role of hereditary factors in venous thromboembolism Source: Eur Respir J 2004; 24: Suppl. 48, 276s Year: 2004 Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis? Source: Eur Respir J 2016; 47: 369-373 Year: 2016 Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism Source: Eur Respir J 2016; 48: 1360-1368 Year: 2016 Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Venous thromboembolic disease and bronchial cancer Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012